Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults

Inclusion Criteria: * Signed Informed Consent; * Adults Male and Female ≥ 18 years old; * Obesity (BMI ≥ 30kg/m2 or ≥ 27 Kg/m2 with associate risk); Exclusion Criteria: * Pregnancy and Lactation or women without effective contraception; * Relevant clinical diseases; * Obesity associated to genetic syndrome; * Decompensated Diabetes; * Psychiatric disorders; * Alimentary disorders; * Use of: anorectics, herbal weight loss and/or constipation and laxatives, in the past 30 days; * Patients using cyclosporine or amiodarone; * Patients with bowel disease; * Prior bariatric surgery; * Anemia; * Hemoglobinopathies and coagulopathy; * History of cancer in the past five years; * Use of corticosteroids, oral or injectable, in the last 30 days.